Life Sciences and Healthcare to Korea

 Expressions of interest are open on 25 November 2025 and close on 1 February 2026 at 11:59PM AEDT.

On this page

About the event

South Korea remains an important market for the life sciences sector and is increasingly significant for attracting Phase I clinical trials, fostering collaborations in medical research, and promoting international partnerships.

BIO KOREA 2026 is one of Asia’s leading biotechnology events, bringing together global innovators, researchers, and investors in the life sciences industry. NSW has strengths that align with South Korea’s priorities, including genomics and genetics, neuroscience, regenerative and personalized medicine, innovative therapeutics and diagnostics, and clinical trials. There is a strong opportunity for NSW to strengthen relationships across these sectors.

Investment NSW is facilitating a four-day program linked to the three-day BIO KOREA Conference. Activities will include a Team Australia welcome function to support NSW life sciences companies in discovering new opportunities, forming partnerships, and promoting the NSW life sciences ecosystem.

Please note the in-market program is subject to change.

In partnership with Austrade, participating companies will have access to the Australian Pavilion at the BIO KOREA exhibition hall, a complimentary conference pass, and multiple networking events.

Key dates

• BIO KOREA 2026, 29 April 2026 to 1 May 2026

In-person attendance by a company representative is compulsory.

Why you should apply

Develop a first-hand understanding of the health & life sciences ecosystem.
Gain first-hand insight into South Korea’s dynamic life sciences and healthcare innovation ecosystem.

Connect with leading Korean government agencies, hospitals, and biotech companies to explore opportunities for collaboration and integration into global supply chains.

Access industry networks and key decision makers across clinical research, pharmaceuticals, and medical technology to identify partnership or public–private collaboration opportunities.

Showcase your organisation’s capabilities and solutions to potential partners and investors through meetings, networking sessions, and speaking opportunities at BIO KOREA 2026.

Build credibility and visibility for your business under the Team Australia brand, supported by Investment NSW and the Australian Government.

Receive tailored support from Investment NSW’s in-market and Sydney-based teams to help you navigate opportunities and strengthen your presence in the South Korean market.

What types of business should apply?

This mission is suitable for NSW businesses that:

Provide products, services and solutions for the health and life sciences industry including, but not limited to, the following areas:
- Medical research/drug development
- Biotechnology
- Medical technology
- Clinical trial service providers
Have a commercially ready product or service.
Have a website featuring the product or service.
Have resources to support marketing and development for a new market.

Eligibility

The applicant business must meet core eligibility criteria for this mission including:

1. Have a demonstrated NSW footprint

Have headquarters in NSW (or demonstrated footprint in NSW and business activity that benefits NSW).
Have a valid Australian Business Number (ABN) registered in NSW (or business activity that demonstrates benefit to NSW.
The product or service must be produced primarily in NSW OR a demonstrated footprint in NSW and business activity that benefits NSW and commitment to expand in NSW.
The applicant business produces and owns their own brand (the program is not for aggregators/traders or consultants).

2. Demonstrate capacity to scale and market suitability

Have demonstrated scalability and capacity to deliver on export opportunities.
Have a suitable product for the identified market and capable to grow through export activity in the identified new market.

3. Agree to the Terms and Conditions of participation in the mission

Be willing to accept the conditions of participation in the mission and travel to the selected market.

Repeating applicants must demonstrate previous commitment and participation in Investment NSW export support programs, including reporting outcomes, and an ongoing commitment to deliver on previous support.

What is included

Investment NSW will support businesses to be part of the NSW delegates at BIO KOREA 2026, which includes:

Pre-event briefing and preparations.
A space within the dedicated Team Australia stand to promote your offering, provide sampling and engage with interested parties.
Printed and digital promotion in Team Australia Exhibitor Directory.
In-market support from Investment NSW’s Trade and Investment Director, Seoul, Republic of Korea and Austrade.
Ongoing one-to-one support with a dedicated Investment NSW Export Advisor following the conclusion of the program.
Networking event and site visits (subject to participants).

Please note: Costs will not include airfares, accommodation, travel insurance, visas, meals, ground transport, any cost associated with freight for product samples and any additional cost that are considered out of scope of the core offer.

About the selection process

Investment NSW will select participants through a merit-based assessment process. Where there are more applicants than places available, places on the mission will be offered to those applicants most suitable for the mission and new to the mission/market.

How to apply

Apply Now

Applications open on 25 November 2025 and close on 1 February 2026 at 11:59PM AEDT.

Contact

For any further information, please contact:

Sarah Lee, Senior Export Advisor Investment NSW | TradeStart Advisor:
sarah.lee@investment.nsw.gov.au